Reconsidering pancreatic masses: A case of IgG4-related autoimmune pancreatitis mimicking malignancy

Key Takeaways for GI Nurses

• IgG4-related autoimmune pancreatitis (AIP) can present with imaging findings nearly identical to pancreatic adenocarcinoma, requiring heightened awareness during pre-procedure patient assessment and education
• Tissue sampling through EUS-guided fine needle aspiration may be essential for definitive diagnosis, emphasizing the critical role of proper specimen handling and coordination with pathology services
• Patient anxiety levels may be particularly elevated due to initial concern for malignancy, requiring enhanced communication skills and emotional support throughout the diagnostic process
• Understanding AIP as a systemic condition helps nurses recognize potential multi-organ involvement and coordinate appropriate interdisciplinary care pathways

Clinical Relevance

This case highlights a significant diagnostic challenge that directly impacts endoscopy nursing practice and patient care coordination. When patients present with pancreatic masses suspicious for malignancy, nurses must be prepared for complex diagnostic workups that may include multiple imaging studies, laboratory tests for IgG4 levels, and tissue sampling procedures. The similarity between AIP and pancreatic cancer on initial imaging means that patients often arrive to the endoscopy unit with considerable anxiety about a potential cancer diagnosis, requiring skilled nursing assessment and communication to provide appropriate emotional support while maintaining realistic expectations about the diagnostic process.

From a procedural standpoint, the diagnosis of IgG4-related AIP often requires EUS-guided tissue sampling, which places additional responsibility on endoscopy nurses for proper specimen handling and processing. Nurses must ensure adequate tissue samples are obtained for both cytological analysis and immunohistochemical staining for IgG4-positive plasma cells. This requires coordination with pathology services and understanding of specific handling requirements that differ from routine pancreatic cancer evaluations. Additionally, since AIP is a systemic autoimmune condition that can affect multiple organs, nurses should be alert to patient histories suggesting involvement of other organ systems, such as inflammatory bowel disease, retroperitoneal fibrosis, or salivary gland enlargement.

The implications extend beyond individual patient care to unit workflow and staff education. Endoscopy teams benefit from understanding that AIP, while mimicking malignancy, represents a treatable condition that typically responds well to corticosteroid therapy. This knowledge helps nurses provide more nuanced patient education and emotional support, particularly when discussing the potential for benign diagnoses in patients initially concerned about cancer. Furthermore, recognition of AIP characteristics supports appropriate scheduling and resource allocation for complex diagnostic cases that may require extended procedure times and specialized tissue handling protocols.

Bottom Line

Endoscopy nurses caring for patients with pancreatic masses must recognize that IgG4-related autoimmune pancreatitis can closely mimic pancreatic cancer, requiring meticulous attention to tissue sampling techniques, enhanced patient communication skills to address cancer-related anxiety, and coordination with multidisciplinary teams to ensure proper diagnostic workup of this treatable autoimmune condition rather than assuming malignancy based on imaging alone.